4//SEC Filing
PROGENICS PHARMACEUTICALS INC 4
Accession 0001266375-08-000004
CIK 0000835887operating
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 3:37 PM ET
Size
12.1 KB
Accession
0001266375-08-000004
Insider Transaction Report
Form 4
Kremer Alton B
VP, Clinical Research
Transactions
- Tax Payment
Common Stock
2008-01-02$18.03/sh−1,036$18,679→ 29,849 total - Award
ESPP (right to buy)
2008-01-02+2,407→ 2,407 totalExercise: $18.07From: 2008-07-01Exp: 2008-07-01→ Common Stock (2,407 underlying) - Exercise/Conversion
ESPP (right to buy)
2008-01-02−1,139→ 0 totalExercise: $15.36From: 2008-01-02Exp: 2008-01-02→ Common Stock (1,139 underlying) - Exercise/Conversion
Common Stock
2008-01-02$15.36/sh+1,139$17,495→ 30,885 total
Footnotes (5)
- [F1]Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise.
- [F2]Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan.
- [F3]Granted under the Company's Non-Qualified Employeee Stock Purchase Plan.
- [F4]The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date.
- [F5]The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the day prior to the exercise date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000835887
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 3:37 PM ET
- Size
- 12.1 KB